1. A. Within 120-days of receiving a completed notice of a proposed transaction, the office shall complete a review, confer with the authority and either:

   1. (1) approve the proposed transaction;
   2. (2) approve the proposed transaction with conditions; or
   3. (3) disapprove the proposed transaction.

2. B. In conducting a review of a proposed transaction, the office may consider the likely effect in New Mexico of the proposed transaction on:

   1. (1) the potential reduction or elimination in access to essential services;
   2. (2) the availability, accessibility and quality of health care services to any community affected by the transaction;
   3. (3) the health care market share of a party and whether the transaction may foreclose competitors of a party from a segment of the market or otherwise increase barriers to entry in a health care market;
   4. (4) changes in practice restrictions for licensed health care providers who work at the hospital;
   5. (5) patient costs, including premiums and out-of-pocket costs;
   6. (6) health care provider networks; and
   7. (7) the potential for the proposed transaction to affect health outcomes for New Mexico residents.
3. C. The review period may be extended if the parties agree to an extension.

[13.2.12.12 NMAC - N/E, 05/15/2024; N, 9/10/2024]